CN Mobile Logo

Search form




In this interview we discuss breast cancer prevention and risk assessments, including the questions these assessments aim to answer, what classifies someone as average or high risk, and appropriate next steps for patients who fall in these categories.

In this interview we discuss prognostic models that may be able to predict disease progression in patients with chronic lymphocytic leukemia treated with the targeted agent ibrutinib.

As part of our coverage of the ASH Annual Meeting, we are discussing novel agents and strategies for relapsed/refractory Hodgkin lymphoma.

In this interview we discuss a recent report from the International Agency for Research on Cancer that evaluated the evidence linking obesity to cancer risk.

In this interview we discuss the idea of using schools to increase knowledge about skin cancer and attitudes toward sun exposure.

In this interview we discuss the different types of T-cell lymphomas and how supportive care is used in the management of these malignancies.

In this interview we discuss symptoms and prognosis for patients with polycythemia vera and essential thrombocythemia and the treatment of myelofibrosis.


Subscribe to Podcasts on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.